Study of X0002 Following Escalating Single and Multiple Doses Administered as Topical Application in Healthy Volunteers

NCT02794740 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: X0002
DRUG: Placebo

Sponsor

Tianjin XinChen-Techfields Pharma Co., LTD.